» Articles » PMID: 30338598

H19 Regulation of Oestrogen Induction of Symmetric Division is Achieved by Antagonizing Let-7c in Breast Cancer Stem-like Cells

Overview
Journal Cell Prolif
Date 2018 Oct 20
PMID 30338598
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Breast cancer stem-like cells (BrCSCs) are the major reason for tumour generation, resistance and recurrence. The turbulence of their self-renewal ability could help to constrain the stem cell expansion. The way BrCSCs divided was related to their self-renewal capacity, and the symmetric division contributed to a higher ability. Non-coding long RNA of H19 was involved in multiple malignant procedures; the role and mechanistic proof of non-coding long RNA of H19 in controlling the divisions of BrCSCs were barely known.

Materials And Methods: Indicative functions of H19 in preclinical study were analysed by using the TCGA data base. Division manners were defined by using fluorescence staining.

Results: We identified the stimulation of H19 on symmetric division of BrCSCs, which subsequently resulted in self-renewing increasing. H19 inhibited the Let-7c availability by acting as its specific molecular sponge, and with Let-7c inhibition, oestrogen receptor activated Wnt signalling was unconstrained. Similarly, restoring Let-7c constrained oestrogen receptor activated Wnt factors, which sequentially inhibited the H19 decreasing of Let-7 bioavailability. Let-7c is reactivated in vitro where H19 was knockdown, and later inhibited the symmetric division of BrCSCs. Reciprocally, Wnt pathway activation leads to H19 increasing, which in turn decreased Let-7c bioavailability.

Conclusions: Our results revealed a previously undescribed double negative feedback loop between sponge H19 and targeted Let-7c through oestrogen activated Wnt signalling that dominated in stem cells' division.

Citing Articles

Exploring the clinical potential of circulating LncRNAs in breast cancer: insights into primary signaling pathways and therapeutic interventions.

Al-Noshokaty T, Abdelhamid R, Reda T, Alaaeldien A, Abdellatif N, Mansour A Funct Integr Genomics. 2024; 24(6):209.

PMID: 39508907 DOI: 10.1007/s10142-024-01476-y.


Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7.

Li K, Peng Z, Wang R, Li X, Du N, Liu D Mol Cancer. 2023; 22(1):103.

PMID: 37393311 PMC: 10314519. DOI: 10.1186/s12943-023-01811-0.


Long non-coding RNAs in breast cancer stem cells.

Huang Y, Mo W, Ding X, Ding Y Med Oncol. 2023; 40(6):177.

PMID: 37178429 DOI: 10.1007/s12032-023-02046-1.


Mechanisms of Long Non-Coding RNA in Breast Cancer.

Giuliani B, Tordonato C, Nicassio F Int J Mol Sci. 2023; 24(5).

PMID: 36901971 PMC: 10002950. DOI: 10.3390/ijms24054538.


Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management.

Melone V, Salvati A, Brusco N, Alexandrova E, DAgostino Y, Palumbo D Int J Mol Sci. 2023; 24(2).

PMID: 36674656 PMC: 9863308. DOI: 10.3390/ijms24021145.


References
1.
Kallen A, Zhou X, Xu J, Qiao C, Ma J, Yan L . The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013; 52(1):101-12. PMC: 3843377. DOI: 10.1016/j.molcel.2013.08.027. View

2.
Pine S, Liu W . Asymmetric cell division and template DNA co-segregation in cancer stem cells. Front Oncol. 2014; 4:226. PMC: 4139651. DOI: 10.3389/fonc.2014.00226. View

3.
Kim C, Tang G, Pogue-Geile K, Costantino J, Baehner F, Baker J . Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. J Clin Oncol. 2011; 29(31):4160-7. PMC: 3208536. DOI: 10.1200/JCO.2010.32.9615. View

4.
Xiao G, Meng J, Zhang J, Li G, Du N, Qin S . Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers. Cancer Invest. 2017; 35(10):639-646. DOI: 10.1080/07357907.2017.1405015. View

5.
Sun X, Jiao X, Pestell T, Fan C, Qin S, Mirabelli E . MicroRNAs and cancer stem cells: the sword and the shield. Oncogene. 2013; 33(42):4967-77. DOI: 10.1038/onc.2013.492. View